Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
Abstract Neoantigens generated by non-synonymous mutations of tumor genes can induce activation of neoantigen-reactive T (NRT) cells which have the ability to resist the growth of tumors expressing specific neoantigens. Immunotherapy based on NRT cells has made preeminent achievements in melanoma an...
Main Authors: | Ruichen Huang, Bi Zhao, Shi Hu, Qian Zhang, Xiaoping Su, Wei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-023-00478-5 |
Similar Items
-
Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
by: Yicheng Zhu, et al.
Published: (2021-06-01) -
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01) -
Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
by: Naiqing Ding, et al.
Published: (2023-01-01) -
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01) -
The Role of Neoantigens in Cancer Immunotherapy
by: Yueting Zhu, et al.
Published: (2021-08-01)